Prism Healthcare

Adviser to Prism’s management team on strategic sale to investor, Charme Capital Partners.

The deal

Prism Healthcare secures private equity investment

We’re pleased to have supported the management team of Prism Healthcare, a provider of specialist healthcare equipment, as it secures new investment from Charme Capital Partners, a pan-European mid-market private equity firm.

Headquartered in Wakefield, Prism Healthcare manufactures and supplies a broad range of products and services to health and care providers across the UK, and internationally through a network of distributors. Its mission is to transform the quality of life of people with health and mobility conditions, enabling them to remain mobile and active in their own homes, in long-term care facilities or in acute care environments.

The company employs more than 650 people across the UK and its portfolio includes safe patient handling, bathing, accessibility, and pressure area care products.

In this latest deal, Charme Capital Partners becomes the business’ majority investor and will be supported by Prism’s existing investor, Limerston Capital.

Over the last three years, with Limerston Capital’s support, Prism has consolidated its position as a market leader in homecare and long-term care services. It has completed four acquisitions to broaden its services and products, expanded into new geographic areas and doubled in size to become the most comprehensive provider in the UK.

With the support and investment of Charme Capital Partners, Prism will now drive further organic expansion through the continued development of its offering and further investment in its IT and manufacturing capabilities. It will also continue to explore complementary acquisitions to drive growth both in the UK and internationally.

Prism’s five-strong management team, including CEO Paul Morton, CFO James Hart and executive chairman Stuart Meldrum, were advised by our Corporate Finance team, led by Director Gary Hyem. The management team retains a stake in the business as part of the deal and will continue to lead the day-to-day running of the company.

Commenting on the deal, Gary said: “I’ve worked closely with Prism Healthcare and the management team for over 15 years, and it has been great to support them on such a huge growth journey. This tertiary buyout and the investment from Charme Capital Partners are testament to the strength of the team, the business they have built and its position as the largest operator in the UK market, and I’m looking forward to seeing where Prism Healthcare goes next as it continues to drive expansion both at home and overseas.”

Paul Morton, CEO of Prism Healthcare, added: “We are thrilled to welcome Charme as a new investor in Prism Healthcare and are confident they are the right partner, with the right skills and experience, to help us realise our ambitious growth objectives. I would like to thank Gary and the team at FRP Corporate Finance for their support on such a landmark deal – we’re excited to embark on a new chapter for Prism Healthcare, whilst continuing to support our customers and their clients in homecare, long term care and the paediatric market by making care easier.”

Deal summary


February 2022



Deal type:

Management advisory, Private equity

Deal size:


I’ve worked closely with Paul, Stuart and the wider management team at Prism Healthcare for close to 20 years and it has been great to support them on such a huge growth journey Gary Hyem Corporate Finance